Evidence map›Paper›PMID 29582396›Full record

ArticleMolecular neurobiology2018

The Effects of Non-selective Dopamine Receptor Activation by Apomorphine in the Mouse Hippocampus.

Luis Enrique Arroyo-García, Rubén Antonio Vázquez-Roque, Alfonso Díaz, Samuel Treviño, Fidel De La Cruz, Gonzalo Flores, Antonio Rodríguez-Moreno

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Base editing ofeLife · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Apomorphine effects on the hippocampus.Neural regeneration research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Luis Enrique Arroyo-GarcíaLaboratorio de Neurociencia Celular y Plasticidad, Universidad Pablo de Olavide, Sevilla, Spain.
Rubén Antonio Vázquez-RoqueLaboratorio de Neuropsiquiatría, Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, 14 Sur 6301, 72570, Puebla, CP, Mexico.
Alfonso DíazFacultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Samuel TreviñoFacultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Fidel De La CruzLaboratorio de Fisiología de la Conducta, Instituto Politécnico Nacional, Mexico City, Mexico.
Gonzalo FloresLaboratorio de Neuropsiquiatría, Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, 14 Sur 6301, 72570, Puebla, CP, Mexico. gonzaloflores56@gmail.com.
Antonio Rodríguez-MorenoLaboratorio de Neurociencia Celular y Plasticidad, Universidad Pablo de Olavide, Sevilla, Spain. arodmor@upo.es.ORCID http://orcid.org/0000-0002-8078-6175
Benemérita Universidad Autónoma de Puebla · MXInstituto Politécnico Nacional · MXUniversidad Pablo de Olavide · ES

Funding

CONACYT 252808Junta de Andalucía CVI-7290MINECO BFU2012-38208VIEP-BUAP FLAG-2016
6 · The paper itself

Abstract

Apomorphine is a dopamine receptor agonist that activates D

Indexed as

AnimalsApomorphineDendritesHippocampusInflammationLong-Term PotentiationMaleMemoryMice, Inbred C57BLOxidation-ReductionPyramidal CellsReceptors, DopamineSpatial LearningApomorphineReceptors, DopamineApomorphineDendritic lengthDopamine receptorHippocampusLearning and memoryOxidative stressPlasticity

Identifiers

PMID29582396
OpenAlexW2789331277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.